| Business Summary | | SurModics,
Inc.
is
a
provider
of
surface
modification
solutions
to
the
medical
device
industry.
The
Company's
primary
focus
is
the
commercialization
of
its
patented
PhotoLink
process
through
third-party
licensing
arrangements.
PhotoLink
is
a
versatile,
easily
applied,
light-activated
coating
technology
that
modifies
medical
device
surfaces
by
treating
covalent
bonds
between
those
surfaces
and
a
variety
of
chemical
agents.
Through
the
PhotoLink
process,
these
chemical
agents
can
impart
many
performance-enhancing
characteristics,
such
as
lubricity,
hemocompatibility,
infection
resistance
and
drug
incorporation,
onto
the
surface
of
a
medical
device
without
materially
changing
the
dimensions
or
physical
properties
of
the
device. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | SurModics
provides
surface
modification
solutions
to
the
medical
device
industry;
the
Company's
primary
focus
is
the
commercialization
of
its
patented
PhotoLink
process
through
licensing
agreements.
For
the
nine
months
ended
6/30/01,
total
revenues
rose
24%
to
$15.8
million.
Net
income
rose
68%
to
$4.6
million.
Revenues
reflect
genomics
work
with
Motorola
and
work
on
Johnson
and
Johnson's
drug
delivery
stent
program.
Net
income
also
reflects
higher
cash
and
investment
balances. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Dale Olseth, 70 Chairman,
CEO | $200K | -- | James Powell, 51 Pres
and COO | 181K | $506K | Stephen Hathaway, 45 CFO,
VP | 151K | 140K | Patrick Guire, Ph.D., 64 Sr.
VP of Research and CSO | 130K | 308K | Walter Diers, Jr., 49 VP
of Corp. Devel. | 143K | 244K | Dollar
amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|